Kearns-Sayre syndrome: A mitochondrial disease (OMIM #530000);Kearns-Sayre-Syndrom: Eine mitochondriale Erkrankung (OMIM #530000)

Ophthalmologe

Volumn 108, Issue 5, 2011, Pages 459-462

  Mayer, W J ^a   Remy, M ^a   Rudolph, G ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Chronic progressive external ophthalmoplegia; Kearns Sayre syndrome; Mitochondrial disease; Muscle biopsy; Ptosis

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; EYE MOVEMENT DISORDER; HUMAN; KEARNS SAYRE SYNDROME; MALE; PTOSIS;

ADOLESCENT; BLEPHAROPTOSIS; HUMANS; KEARNS-SAYRE SYNDROME; MALE; OCULAR MOTILITY DISORDERS;

EID: 79956075131     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-010-2296-3     Document Type: Article

References (18)

1. Barbiroli B, Iotti S, Lodi R (1999) Improved brain and muscle mitochondrial respiration with CoQ. An in vivo study by 31P-MR spectroscopy in patients with mitochondrial cytopathies. Biofactors 9: 253-260.
2. Biousse V, Newman NJ (2003) Neuro-ophthalmology of mitochondrial diseases. Curr Opin Neurol 16: 35-43.
3. Drachman DA (1968) Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 18: 654-674.
4. Haufroid V, Clippe A, Knoops B et al (1998) Genotyping in urine: an interesting tool for epidemiological studies. Clin Chem 44: 2210-2211.
5. Kaiser KJ, J. F (1999) Kinderophthalmologie - Auge und Allgemeinerkrankungen. Hans Huber, Basel.
6. Kearns T, Sayre G (1958) Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 60: 280-289.
7. Lebrecht D, Kokkori A, Ketelsen UP et al (2005) Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J Pathol 207: 436-444.
8. Lestienne P, Ponsot G (1988) Kearns-Sayre syndrome with muscle mitochondrial DNA deletion. Lancet 1: 885.
9. Markaryan A, Nelson EG, Hinojosa R (2008) Detection of mitochondrial DNA deletions in the cochlea and its structural elements from archival human temporal bone tissue. Mutat Res 640: 38-45.
10. Mashima Y, Hiida Y, Oguchi Y (1992) Remission of Leber's hereditary optic neuropathy with idebenone. Lancet 340: 368-369.
11. Mayr JA, Merkel O, Kohlwein SD et al (2007) Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 80: 478-484.
12. Mohri I, Taniike M, Fujimura H et al (1998) A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up. J Neurol Sci 158: 106-109.
13. Park SB, Ma KT, Kook KH et al (2004) Kearns-Sayre syndrome -3 case reports and review of clinical feature. Yonsei Med J 45: 727-735.
14. Rowland L, Hays A, Di Mauro S et al (1983) Diverse cinical disorders associated with morphological abnormalities of mitochondria. In: Scarlato G, Cerri C (Hrsg) Mitochondrial pathology in muscle diseases. Piccin Medical Books, Padova, S 141-158.
15. Schaefer AM, Blakely EL, Griffiths PG et al (2005) Ophthalmoplegia due to mitochondrial DNA disease: the need for genetic diagnosis. Muscle Nerve 32: 104-107.
16. Serrano M, Garcia-Silva MT, Martin-Hernandez E et al (2010) Kearns-Sayre syndrome: Cerebral folate deficiency, MRI findings and new cerebrospinal fluid biochemical features. Mitochondrion.
17. Taylor RW, Schaefer AM, Barron MJ et al (2004) The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 14: 237-245.
18. Wabbels B, Ali N, Kunz WS et al (2008) Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome: interdisciplinary diagnosis and therapy; Chronisch-progressive externe Ophthalmoplegie und Kearns-Sayre-Syndrom: Interdisziplinäre Diagnostik und Therapie. Ophthalmologe 105: 550-556.